United States: New FAQs Address Implementation Of The Affordable Care Act, Mental Health Parity And Addiction Equity Act, And The Women's Health And Cancer Rights Act


Recent guidance clarifies important issues under the Affordable Care Act, Mental Health Parity and Addiction Equity Act, and Women’s Health and Cancer Rights Act.

In Depth

The US Departments of Labor (DOL), Health and Human Services (HHS) and Treasury (collectively, the Departments) published frequently asked questions (FAQs) on April 20, 2016, clarifying the implementation of the Affordable Care Act (ACA), the Mental Health Parity and Addiction Equity Act of 2008 (MHPAEA), and the Women's Health and Cancer Rights Act of 1998 (WHCRA) and their regulations.  The topics addressed in this most recent set of FAQs include coverage of preventive services, rescissions, out-of-network emergency services, coverage for individuals participating in approved clinical trials, cost sharing limitations, mental health parity requirements, and required coverage following a mastectomy.

Coverage of Preventive Services

The ACA requires non-grandfathered group health plans and health insurance issuers in the group and individual markets to provide coverage of certain preventive services recommended by the US Preventive Services Task Force (USPSTF) without any cost-sharing. The subcategories are broken down into evidence-based items or services, immunizations, coverage for children at all stages of growth and women.

Under the FAQs, the Departments clarify that if a colonoscopy is scheduled and performed as a screening procedure pursuant to USPSTF recommendations, plans and issuers may not impose cost sharing for the bowel preparation medications prescribed for the procedure.  The Departments view such medications as an integral part of the preventive screening colonoscopy (when medically appropriate and prescribed) that are therefore required to be covered, subject to reasonable medical management.

In addition, non-grandfathered group health plans and health insurance issuers, as described above, are also required to provide contraceptive methods, sterilization procedures, and patient education and counseling for all women with reproductive capacity. These most recent FAQs referred to February 20, 2013, and May 11, 2015, FAQs on this subject. Addressing the exceptions process under reasonable medical management for a particular FDA-approved contraceptive method, the Departments state that plans and issuers may develop and utilize a standard exception form and instructions to help ensure that it provides the required process for individuals and medical providers to prescribe a particular contraceptive service or FDA-approved item based on a determination of medical necessity regarding the individual involved.  The FAQs clarify that the Medicare Part D Coverage Determination Request Form may be used as a model form for plans and issuers when developing their standard exception form.


The ACA generally provides that health plans and issuers must not retroactively cancel or discontinue (i.e., "rescind") coverage except in the case of fraud or when a person makes an intentional misrepresentation of material fact.  Under the FAQs, the Departments provide a relevant example and clarify that a retroactive cancellation or discontinuance of coverage is considered a "rescission" only to the extent it is not attributable to a failure to pay timely premiums towards coverage, due to fraud or intentional misrepresentation of material fact, or in certain other limited circumstances specified in the regulations.

Out-of-Network Emergency Services

Under the ACA, non-grandfathered group health plans and health insurance issuers offering non-grandfathered group or individual health insurance coverage may not impose cost sharing (co-payments or a co-insurance rate) on out-of-network emergency services that is higher than what they impose for in-network emergency services.  The relevant statute, however, does not include in the statutory definition of "cost sharing" the practice of "balance billing," which refers to the practice of medical providers billing individuals for the difference between (1) the provider's billed charges, and (2) the amount collected from the health plan or insurance issuer, plus the amount collected from the individual in the form of a copayment or coinsurance amount.  However, while the ACA does not prohibit balance billing (please note however, that some state laws prohibit balance billing), a reasonable amount must be paid by a health plan or insurance issuer before a patient becomes responsible for a balance billed amount.  Thus, the regulations provide that out-of-network emergency services must be covered in an amount at least equal to the greatest of the following three amounts, known as the "minimum payment standards," adjusted for in-network cost sharing:

  1. The median amount negotiated with in-network providers for the emergency service
  2. The amount for the emergency service calculated using the same method the plan generally uses to determine payments for out-of-network services (such as the usual, customary, and reasonable (UCR) amount)
  3. The amount that would be paid under Medicare for the emergency service

Under the FAQs, the Departments provide that a health plan or issuer is required to disclose to plan participants upon request how it calculated the minimum-payment standard amount, including the usual, customary and reasonable (UCR) amount, for out-of-network emergency services.

Coverage for Individuals Participating in Certain Clinical Trials

Under the ACA, if a non-grandfathered group health plan or health insurance issuer offering non-grandfathered group or individual coverage provides coverage to a qualified individual, then such plan or issuer may not deny participation in or coverage of routine patient costs for items and services furnished in connection with an approved clinical trial with respect to the prevention, detection or treatment of cancer, or another life-threatening disease or condition, and may not discriminate against the individual on the basis of the individual's participation in the clinical trial.

Clarifying these requirements, the FAQs provide that if a health plan or issuer generally covers chemotherapy to treat cancer, then it may not deny (or limit or impose additional conditions on) coverage for any items or services furnished in connection with participation in an approved clinical trial, which could include, for example, coverage for a new anti-nausea medication.  In addition, the FAQs clarify that if a health plan or issuer typically covers items and services to diagnose or treat complications or adverse events, it may not deny coverage of such items and services when provided to diagnose or treat complications or adverse events in connection with an individual's participation in an approved clinical trial.

The FAQs clarify that patient costs do not include (1) the investigational item, device or service being studied in the approved clinical trial; (2) items and services that are provided solely to satisfy the clinical trial's data collection and analysis needs and that are not used in the direct clinical management of the patient; and (3) a service that is clearly inconsistent with widely accepted and established standards of care for a particular diagnosis. In addition, a group health plan, or a health insurance issuer offering group or individual health insurance coverage is not required to provide routine patient care services outside of the plan's (or coverage's) health care provider network, unless out-of-network benefits are otherwise provided under the plan (or coverage).

Limitations on Cost-Sharing

The ACA provides that any annual cost-sharing imposed under a non-grandfathered group health plan may not exceed the out-of-pocket cost limitations provided for under the ACA.  For plan or policy years beginning in 2016 and 2017, the annual limitation on out-of-pocket costs is set forth in the table below:




Self-Only Coverage



Other Than Self-Only Coverage



Future limits will be increased by a statutorily defined percentage.

The FAQs clarify that if a non-grandfathered large group market or self-insured group health plan pays a fixed amount (sometimes referred to as a "reference price") for a particular procedure, but does not ensure that participants have adequate access to quality providers that will accept the reference price as payment in full, it is required to count an individual's out-of-pocket expenses for providers who do not accept the reference price toward the participant's maximum out-of-pocket limit.

Mental Health Parity and Addiction Equity Act

The MHPAEA generally requires group health plans (or health insurance coverage offered in connection with such a plan) to provide parity between medical and surgical benefits and mental health and/or substance use disorder benefits and provides that mental health and substance use disorder services are essential health benefits.  The Departments published final regulations and FAQs on MHPAEA in November 2013 and has since issued updated guidance in the form of FAQs.  

These most recent FAQs clarify the effect of the ACA on mental health parity by providing the following guidance:

  • When performing the "substantially all" and "predominant" tests for financial requirements and quantitative treatment limitations when determining parity under MHPAEA, a health plan or issuer may not base the analysis on an issuer's entire overall book of business for the year.  The Departments clarify that basing the analysis on an issuer's entire overall book of business expected to be paid for the year or book of business in a specific region or state is not a reasonable method to determine the dollar amount of all plan payments under MHPAEA.  A self-insured group health plan must generally use plan-specific data when available. For small group insurers, data at the "plan" level rather than at the "product" level must be used, unless the insurer does not have enough data at the plan level. 
  •  MHPAEA's disclosure provisions require that a plan must, upon request, disclose the criteria for medical necessity determinations with respect to mental health or substance use disorder benefits (MH/SUD) to any current or potential participant, beneficiary, or contracting provider upon request and the reason for any denial of reimbursement or payment for services with respect to MH/SUD benefits to the participant or beneficiary, as well as (if an ERISA-covered plan) provide certain documents and plan information to a medical provider acting as an authorized representative for a participant.  The required documents and information in the fact pattern set forth in the FAQs is rather expansive and includes the following:

    • Summary plan description
    • Specific plan language regarding the imposition of a non-quantitative treatment limitation (NQTL)
    • Specific processes, strategies, evidentiary standards and other factors considered by the plan in determining that the NQTL will apply to the MH/SUD benefit at issue
    • Information regarding the application of the NQTL to any medical/surgical benefits within the benefit classification at issue
    • The specific underlying processes, strategies, evidentiary standards and other factors considered by the plan in determining the extent to which the NQTL will apply to any medical/surgical benefits within the benefit classification at issue
    • Any analyses performed by the plan as to how the NQTL complies with the MHPAEA
  • The criteria for medical necessity determinations under a group health plan or health insurance coverage with respect to mental health and substance use disorder benefits must be made available to any current or potential enrollee or contracting provider upon request.
  • Clarified that MHPAEA applies to any benefits a plan may offer for medication-assisted treatment for opioid use disorder.
  • Note that most of the above items are also required to be furnished to plan participants and authorized representatives in connection with adverse benefit determinations under the ERISA claims and appeal procedures applicable to group health plans. 

Women's Health and Cancer Rights Act

The WHCRA requires that if a group health plan or health insurance issuer offering group or individual health insurance coverage covers mastectomies, the plan or issuer must provide coverage for certain services, in a manner determined in consultation with the attending physician and the patient. Required coverage includes all stages of reconstruction of the breast on which the mastectomy was performed, surgery and reconstruction of the other breast to produce a symmetrical appearance, prostheses, and treatment of physical complications of the mastectomy, including lymphedema.  These new FAQs clarify that nipple and areola reconstruction and repigmentation are a required stage of breast reconstruction under WHCRA.

Implications for Employers

As it has done in the past, the Departments will likely continue to issue additional guidance in the form of FAQ.  These FAQs cover a broad spectrum of ACA related compliance issues and are often fact-specific.  Employers and plan administrators should carefully review each new FAQ as they are released to ensure that their health plan is set up and administered in compliance with this new guidance.  Plan sponsors should also confirm that any third-party administrator to whom it has delegated discretionary authority to decide claims under the group health plan are administering the plan in accordance with the new guidance set forth in these FAQs.  Failure to operate a group health plan in accordance with the insurance market reforms under the ACA can subject employers and health insurance issuers to significant penalties under the ACA, the Public Health Services Act and the Employment Retirement Income Security Act of 1974.  

New FAQs Address Implementation of the Affordable Care Act, Mental Health Parity and Addiction Equity Act, and the Women's Health and Cancer Rights Act

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.